NASDAQ · STOCK
Cencora
$311.93
52W $244.82 – $377.54
56/100
$60.57B
23.7
0.58
Is COR Bullish or Bearish?
Mixed.
Innellis AI committee rates Cencora (COR) Watch with a composite score of 56/100
, based on 7 analysts with 57% agreement.
Last updated August 01, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +3.58 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -16.42 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Growth Analyst sees a compelling case — eps growing 51.3% yoy. Risk Analyst remains cautious — high leverage (debt-to-equity 5.08) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- ROE of 115.9% shows genuine earnings power backing the valuation — Value
- EPS growing 51.3% YoY — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- Price-to-book of 40.2x prices in significant intangible value — Value
- Debt-to-equity of 5.08 adds balance-sheet risk to the value case — Value
- High leverage (debt-to-equity 5.08) amplifies downside in a stress scenario — Risk
- Current ratio of 0.90 is tight -- limited short-term liquidity cushion — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 01, 2026
Overall Committee Score
56/100
Agreement
57%
Analysts
7
Conviction
Contested
Sector Rank
Top 58%
of 93 Healthcare peers
Value Analyst
neutral
50
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 115.9% shows genuine earnings power backing the valuation
− Price-to-book of 40.2x prices in significant intangible value
Growth Analyst
bullish
70
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ EPS growing 51.3% YoY
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ MACD histogram positive -- bullish momentum
Risk Analyst
bearish
32
/ 100 · Moderate confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 5.08) amplifies downside in a stress scenario
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
bullish
66
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.27 across 21 articles, 14d)
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2535.03)
Investment Thesis Evolution
Committee score moved marginally from 54.6 to 56.4.
- Committee agreement increased notably from 43% to 57%.
- New bearish signals: 2 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- New bullish signals: 1 appeared.
- Bearish pressure eased: 2 signal(s) disappeared.
- Analyst(s) changed stance: Macro Analyst.
Analyst-level changes:
- Macro Analyst: stance neutral->bullish; score 58->70 (+12).
- News Analyst: +1 bullish signal(s).
- Portfolio Manager: +2 bearish signal(s).
Comparing 2026-07-31 to 2026-08-01 (1 day apart).
Technical Analysis
RSI (14)
57.3
Neutral
MACD Histogram
0.168
Bullish Momentum
Trend Direction
Sideways
Weekly: Sideways
Market Structure
Mixed
Support
$286.13
Resistance
$376.69
Bollinger %B
0.71
Inside Bands
Price vs Moving Averages
EMA 9
$311.08
Above
EMA 21
$304.90
Above
EMA 50
$298.01
Above
EMA 200
$307.25
Above
Fundamental Analysis
Valuation
55
Growth
61
Profitability
1
Financial Health
6
Cash Flow
37
Valuation
P/E Ratio
23.7×
P/B Ratio
17.83×
PEG Ratio
0.46
Dividend Yield
0.01%
52W High
$377.54
52W Low
$244.82
Quality & Growth
ROE
103.1%
ROA
2.0%
Gross Margin
3.5%
Operating Margin
1.3%
Revenue Growth YoY
—
Debt / Equity
3.65
AI Fundamental Assessment
P/E ratio of 23.7 (inexpensive relative to a 15-40x range); Price-to-book of 17.8x; PEG ratio of 0.5 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 1.0%; Return on assets of 0.0%; Net margin of 0.0%; Gross margin of 0.0%; Current ratio of 0.95 (tight short-term liquidity); Debt-to-equity of 3.65; Free cash flow margin of 0.7% (thin cash generation); Free cash flow per share is positive (8.01); Most recent quarter missed estimates by 2.3%; EPS growth accelerating (+6.3% -> +16.4% QoQ); Analyst estimates rising over recent quarters
Get the Full COR Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →